Skip to main content
Daniel Bauer, MD, Pediatric Hematology & Oncology, Boston, MA, Dana-Farber Cancer Institute

DanielEBauerMDPhD

Pediatric Hematology & Oncology • Boston, MA

Pediatric Anemia and Red Blood Cell Hematology

Staff Physician, Boston Children's Hospital and Dana-Farber Cancer Institute / Associate Professor of Pediatrics, Harvard Medical School

Join to view full profile

Dr. Bauer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bauer's full profile

Already have an account?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2008 - 2012
  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2006 - 2008
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2025
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Journal Articles

  • CRISPRO: Identification of Functional Protein Coding Sequences Based on Genome Editing Dense Mutagenesis  
    Daniel Bauer, MD, BioMed Central

Abstracts/Posters

  • CRISPR-Cas9 Screen Identifies XPO7 As a Potential Therapeutic Target for TP53-Mutated AML
    Daniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Durable and Robust Fetal Globin Induction without Anemia in Rhesus Monkeys Following Autologous Hematopoietic Stem Cell Transplant with BCL11A Erythroid Enhancer Editing
    Daniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Therapeutic Base Editing of Human Hematopoietic Stem Cells
    Daniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Transcriptional Signaling Centers Govern Human Erythropoiesis and Harbor Genetic Variations of Red Blood Cell Traits 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Opportunities for Scientists in Hematology: Nothing Basic About Discovery 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

  • Boston Woman Adopts 3 Girls That Have Same Incurable Blood Disease She Has: ‘It’s a Miracle We Found Each Other’
    Boston Woman Adopts 3 Girls That Have Same Incurable Blood Disease She Has: ‘It’s a Miracle We Found Each Other’June 12th, 2017
  • FDA Poised to Approve First Gene-Editing Therapy, Made by Local Drug Firms
    FDA Poised to Approve First Gene-Editing Therapy, Made by Local Drug FirmsDecember 4th, 2023
  • Patients with Sickle Cell Disease Urge FDA to Greenlight Landmark Gene-Editing Treatment
    Patients with Sickle Cell Disease Urge FDA to Greenlight Landmark Gene-Editing TreatmentNovember 2nd, 2023
  • Join now to see all

Hospital Affiliations

Dr. Daniel Bauer, Dr. Daniel Bauer, MD, Dr. D Bauer, Dr. Daniel E Bauer